ES2044893T3 - Un anticuerpo monoclonal especifico para un inhibidor de la coagulacion. - Google Patents

Un anticuerpo monoclonal especifico para un inhibidor de la coagulacion.

Info

Publication number
ES2044893T3
ES2044893T3 ES87116671T ES87116671T ES2044893T3 ES 2044893 T3 ES2044893 T3 ES 2044893T3 ES 87116671 T ES87116671 T ES 87116671T ES 87116671 T ES87116671 T ES 87116671T ES 2044893 T3 ES2044893 T3 ES 2044893T3
Authority
ES
Spain
Prior art keywords
coagulation inhibitor
monoclonal antibody
specific monoclonal
derived
human placenta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87116671T
Other languages
English (en)
Inventor
Hiroshi Nakao
Takao Nagoya
Yushi Saino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of ES2044893T3 publication Critical patent/ES2044893T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRESENTA UN ANTICUERPO MONOCLONAL ESPECIFICO PARA UN INHIBIDOR DE COAGULACION DERIVADO DE PLACENTA HUMANA. EL ANTICUERPO SE PRODUCE CULTIVANDO UN HIBRIDOMA QUE LO SEGREGA. UN INHIBIDOR DE COAGULACION DERIVADO DE PLACENTA HUMANA PUEDE PLANIFICARSE USANDO EL ANTICUERPO MONOCLONAL COMO UN INMUNOADSORBENTE. EL INHIBIDOR DE COAGULACION DERIVADO DE PLACENTA HUMANA PUEDE ENSAYARSE INMUNOLOGICAMENTE USANDO LOS ANTICUERPOS MONOCLONALES.
ES87116671T 1986-11-14 1987-11-11 Un anticuerpo monoclonal especifico para un inhibidor de la coagulacion. Expired - Lifetime ES2044893T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61269588A JPH08840B2 (ja) 1986-11-14 1986-11-14 抗ｐｃｉモノクローナル抗体、これを用いた抗ｐｃｉの精製法及び免疫学的測定法

Publications (1)

Publication Number Publication Date
ES2044893T3 true ES2044893T3 (es) 1994-01-16

Family

ID=17474448

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87116671T Expired - Lifetime ES2044893T3 (es) 1986-11-14 1987-11-11 Un anticuerpo monoclonal especifico para un inhibidor de la coagulacion.

Country Status (7)

Country Link
US (2) US5192694A (es)
EP (1) EP0267601B1 (es)
JP (1) JPH08840B2 (es)
KR (1) KR960013460B1 (es)
CA (1) CA1335354C (es)
DE (1) DE3780256T2 (es)
ES (1) ES2044893T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
US5607841A (en) * 1994-06-20 1997-03-04 Lipinski; Boguslaw Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen
EP0741144B1 (en) * 1994-11-11 2002-07-24 Noboru Kaneko Antiannexin-v monoclonal antibody, process for producing the same, and use therof
US6962903B2 (en) * 2001-02-21 2005-11-08 Alavita, Inc. Modified annexin proteins and methods for preventing thrombosis
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US6982154B2 (en) * 2002-02-21 2006-01-03 Surromed, Inc. Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2842467A1 (de) * 1978-09-29 1980-04-10 Behringwerke Ag Neues ubiquitaeres gewebsprotein pp tief 8
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
KR930007434B1 (ko) * 1984-09-21 1993-08-10 베링거 잉겔하임 인터내셔날 게엠베하 혈액응고 억제 단백질 제조방법
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
US4751084A (en) * 1986-02-26 1988-06-14 Monsanto Company Tissue plasminogen activator from normal human colon cells
AU1299788A (en) * 1987-02-06 1988-08-24 Board Of Regents Of The University Of Washington, The Human proteins having anticoagulant and anti-inflammatory activity
US4937324A (en) * 1987-02-06 1990-06-26 Zymogenetics, Inc. Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity

Also Published As

Publication number Publication date
CA1335354C (en) 1995-04-25
EP0267601B1 (en) 1992-07-08
EP0267601A3 (en) 1988-10-12
US5192694A (en) 1993-03-09
DE3780256T2 (de) 1993-01-28
KR890008313A (ko) 1989-07-10
US5290915A (en) 1994-03-01
JPS63123395A (ja) 1988-05-27
KR960013460B1 (ko) 1996-10-05
EP0267601A2 (en) 1988-05-18
JPH08840B2 (ja) 1996-01-10
DE3780256D1 (de) 1992-08-13

Similar Documents

Publication Publication Date Title
ATE40602T1 (de) Immunchemisches messverfahren.
DK150229C (da) Ultrasonisk forstoever samt fremgangsmaade til fremstilling af denne
DK23183A (da) Fremgangsmaade til fremstilling af humane monoclonale antistoffer
NO772635L (no) Skj{reapparat for plantevekster.
WO1990010709A3 (en) Monoclonal antibodies for metallic cations on small molecules
NO793156L (no) Styreorgan for ring-laser-gyroskop.
AR217576A1 (es) Procedimiento para producir un factor antihemofilico,preparado a partir de plasma de sangre humana
DK99682A (da) Immunoanalysemetoder under anvendelse af monoklonale antistoffer
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ES2049332T3 (es) Procedimiento para la reduccion de la heterogeneidad de los anticuerpos monoclonales.
ES2044893T3 (es) Un anticuerpo monoclonal especifico para un inhibidor de la coagulacion.
DK188481A (da) Fremgangsmaade til fremstilling af et organisk platinkompleks
NL7800466A (nl) Werkwijze voor onderzoek op malabsorptie.
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
SE7706551L (sv) Stort, efterspent takfelt, som bestar av flera fortillverkade takelement av armerad betong, samt forfarande for framstellning av takelement och takfelt
IT7824930A0 (it) Dispositivo per fissare tacchi.
DK355483D0 (da) Monoklonale antistoffer til krydsafstemning af humant vaev
ES491376A0 (es) Un procedimiento para la determinacion cuantitativa de enzi-mas proteoliticas
NL7808682A (nl) Lichtgeleideraftakking.
DK0387873T3 (da) Anti-humant spermaantistof, fremstilling og anvendelse deraf
DK122577A (da) Fremgangsmade til fremstilling af blandede proteinfibre
NO158549C (no) Fremgangsmaate for avsverting av sverteholdige sekundaere fiberkilder.
DK38278A (da) Fremgangsmaade til fremstilling af vandige polyusocyanat-emulsioner
DK367079A (da) Fremgangsmaade til drift af svinestalde
AR215457A1 (es) Procedimiento de fabricacion de cuero artificial,a partir de residuos de origen animal

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 267601

Country of ref document: ES